License Exclusions. The license granted to Cardiome pursuant to Section 2.1 specifically excludes: (a) any right under the SteadyMed Technology to Manufacture, or have Manufactured, Finished Product, API, Drug Product, Device, any Device component, Finished IS or any Finished IS component; and (b) any right under the SteadyMed Technology to use, sell, have sold, offer for sale, import or Commercialize: (i) any Product other than Finished Product, Bright Stock or Finished IS supplied by SteadyMed hereunder; (ii) API, Drug Product, Device or any Device component except, in each case, as incorporated in Finished Product, Bright Stock or Finished IS supplied by SteadyMed hereunder; (iii) any subcutaneous, intravenous or other infusion device to connect Finished Product (or the Device incorporated therein) or Bright Stock to the patient’s body, other than Finished IS; (iv) Finished IS independently of Finished Product or Bright Stock or for any use other than use with Finished Product or Bright Stock; and (v) Infusion Sets, other than Finished IS supplied by SteadyMed hereunder. In addition, and for the avoidance of doubt, the license granted to Cardiome pursuant to Section 2.1 excludes any license or other right with respect to any Other Drug, including, without limitation, any Device or other product using SteadyMed Technology that is pre-filled with any Other Drug or that an end user may pre-fill with any Other Product, or any Infusion set for use with any Other Drug.
Appears in 3 contracts
Samples: Exclusive License and Supply Agreement (Correvio Pharma Corp.), Exclusive License and Supply Agreement (SteadyMed Ltd.), Exclusive License and Supply Agreement (Cardiome Pharma Corp)